Latest Insider Transactions at Puma Biotechnology, Inc. (PBYI)
This section provides a real-time view of insider transactions for Puma Biotechnology, Inc. (PBYI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PUMA BIOTECHNOLOGY, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PUMA BIOTECHNOLOGY, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2024
|
Michael Patrick Miller Director |
SELL
Open market or private sale
|
Direct |
23,358
-33.2%
|
$70,074
$3.49 P/Share
|
|
Jul 17
2024
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,156
-2.49%
|
$12,468
$3.7 P/Share
|
|
Jul 17
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,598
-2.15%
|
$7,794
$3.7 P/Share
|
|
Jul 17
2024
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
3,637
-2.66%
|
$10,911
$3.7 P/Share
|
|
Jul 17
2024
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
21,920
-0.31%
|
$65,760
$3.7 P/Share
|
|
Jul 02
2024
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,295
-3.08%
|
$15,885
$3.27 P/Share
|
|
Jul 02
2024
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
4,349
-3.08%
|
$13,047
$3.27 P/Share
|
|
Jul 02
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,051
-4.76%
|
$18,153
$3.27 P/Share
|
|
Jul 02
2024
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
18,885
-0.27%
|
$56,655
$3.27 P/Share
|
|
Jun 18
2024
|
Brian M Stuglik Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+26.2%
|
-
|
|
Jun 18
2024
|
Troy Edward Wilson Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+49.68%
|
-
|
|
Jun 18
2024
|
Michael Patrick Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+22.07%
|
-
|
|
Jun 18
2024
|
Adrian Senderowicz Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+50.0%
|
-
|
|
Jun 18
2024
|
Alessandra Cesano Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+33.33%
|
-
|
|
Jun 18
2024
|
Allison Dorval Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+31.03%
|
-
|
|
Jun 18
2024
|
Jay M Moyes Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+35.85%
|
-
|
|
Jun 13
2024
|
Brian M Stuglik Director |
SELL
Open market or private sale
|
Direct |
9,900
-16.79%
|
$29,700
$3.39 P/Share
|
|
Jun 13
2024
|
Troy Edward Wilson Director |
SELL
Open market or private sale
|
Direct |
27,000
-98.72%
|
$81,000
$3.33 P/Share
|
|
Jun 13
2024
|
Jay M Moyes Director |
SELL
Open market or private sale
|
Direct |
22,000
-50.78%
|
$66,000
$3.34 P/Share
|
|
Jun 13
2024
|
Adrian Senderowicz Director |
SELL
Open market or private sale
|
Direct |
27,000
-100.0%
|
$81,000
$3.33 P/Share
|
|
Jun 13
2024
|
Allison Dorval Director |
SELL
Open market or private sale
|
Direct |
11,000
-25.0%
|
$33,000
$3.37 P/Share
|
|
Mar 15
2024
|
Alan H Auerbach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,577
+0.09%
|
-
|
|
Feb 12
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,067
+17.56%
|
-
|
|
Feb 12
2024
|
Maximo F Nougues Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,307
+20.12%
|
-
|
|
Feb 12
2024
|
Alvin F Wong Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,307
+23.47%
|
-
|
|
Feb 12
2024
|
Alan H Auerbach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
160,796
+2.22%
|
-
|
|
Feb 12
2024
|
Douglas M Hunt Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,894
+21.16%
|
-
|
|
Jan 03
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,956
-11.47%
|
$51,824
$4.49 P/Share
|
|
Jan 03
2024
|
Alvin F Wong Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,733
-7.3%
|
$30,932
$4.49 P/Share
|
|
Jan 03
2024
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
41,396
-0.59%
|
$165,584
$4.49 P/Share
|
|
Jan 03
2024
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,682
-10.86%
|
$62,728
$4.49 P/Share
|
|
Jan 03
2024
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
8,358
-7.48%
|
$33,432
$4.49 P/Share
|
|
Dec 04
2023
|
Alvin F Wong Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
280
-0.29%
|
$840
$3.76 P/Share
|
|
Nov 07
2023
|
Michael Patrick Miller Director |
SELL
Open market or private sale
|
Direct |
25,000
-36.57%
|
$50,000
$2.83 P/Share
|
|
Jul 03
2023
|
Alvin F Wong Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,938
-6.15%
|
$20,814
$3.31 P/Share
|
|
Jul 03
2023
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,680
-9.23%
|
$44,040
$3.31 P/Share
|
|
Jul 03
2023
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
7,809
-6.54%
|
$23,427
$3.31 P/Share
|
|
Jul 03
2023
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,103
-9.68%
|
$36,309
$3.31 P/Share
|
|
Jul 03
2023
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
60,698
-0.86%
|
$182,094
$3.31 P/Share
|
|
Jun 13
2023
|
Jay M Moyes Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+38.39%
|
-
|
|
Jun 13
2023
|
Jay M Moyes Director |
SELL
Open market or private sale
|
Direct |
22,000
-57.41%
|
$66,000
$3.45 P/Share
|
|
Jun 13
2023
|
Troy Edward Wilson Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+49.68%
|
-
|
|
Jun 13
2023
|
Troy Edward Wilson Director |
SELL
Open market or private sale
|
Direct |
27,000
-98.72%
|
$81,000
$3.45 P/Share
|
|
Jun 13
2023
|
Brian M Stuglik Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+31.41%
|
-
|
|
Jun 13
2023
|
Brian M Stuglik Director |
SELL
Open market or private sale
|
Direct |
9,900
-23.65%
|
$29,700
$3.46 P/Share
|
|
Jun 13
2023
|
Allison Dorval Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+38.03%
|
-
|
|
Jun 13
2023
|
Allison Dorval Director |
SELL
Open market or private sale
|
Direct |
10,000
-37.04%
|
$30,000
$3.45 P/Share
|
|
Jun 13
2023
|
Adrian Senderowicz Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+50.0%
|
-
|
|
Jun 13
2023
|
Adrian Senderowicz Director |
SELL
Open market or private sale
|
Direct |
27,000
-100.0%
|
$81,000
$3.45 P/Share
|
|
Jun 13
2023
|
Michael Patrick Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+28.31%
|
-
|